ARGX argenx SE American Depositary Shares Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
11:07
Aug 26
Aug 26
Wall Street analysts issued a broad batch of upgrades and downgrades across multiple sectors.
Wall Street analysts issued a broad batch of upgrades and downgrades across multiple sectors, with price target adjustments for companies including DTM, ARGX, NEOG, SEDG, TYGO, RNW, TJX, EPAM, TRUP, DKS, NKE, GDDY, INTU, and CNM.
02:40
Aug 18
Aug 18
Truist Securities raises its price target on Argenx to 1,095 dollars from 1,030 dollars.
Truist Securities raises its price target on Argenx to 1,095 dollars from 1,030 dollars, indicating a more bullish outlook.
08:10
Aug 17
Aug 17
Argenx shares jumped after the European biotech reported a large successful trial for its.
Argenx shares jumped after the European biotech reported a large successful trial for its blockbuster drug Vyvgart.
04:37
Aug 17
Aug 17
Piper Sandler raises Argenx price target to 1,215 dollars from 1,075.
Piper Sandler raises Argenx price target to 1,215 dollars from 1,075, signaling an upgraded bullish outlook on the stock.
12:36
Jul 27
Jul 27
Pre-market movers include Nvidia discussing a financing backstop for OpenAI's data center.
Pre-market movers include Nvidia discussing a financing backstop for OpenAI's data center, Baker Hughes beating estimates, Rocket Lab winning a Space Force contract, and Fortress Biotech being acquired by Argenx for $77 per share.
05:48
Jul 27
Jul 27
The tweet highlights recent M&A activity in biotech involving ARGX and FBRX.
The tweet highlights recent M&A activity in biotech involving ARGX and FBRX, celebrating gains for FBRX longs and noting a flurry of deals in the sector.
LOW
05:35
Jul 27
Jul 27
Argenx agrees to acquire Forte Biosciences for approximately 2.2 billion dollars in cash.
Argenx agrees to acquire Forte Biosciences for approximately 2.2 billion dollars in cash to expand its immunology drug pipeline.
00:55
Jul 05
Jul 05
BofA raised price target on ARGX; framed as late-cycle defensive positioning.
BofA raised price target on ARGX; framed as late-cycle defensive positioning in a grinding-higher but potentially choppy market.
MED
08:04
Jun 30
Jun 30
The tweet reports a list of stocks receiving analyst upgrades but does not state the author's.
The tweet reports a list of stocks receiving analyst upgrades but does not state the author's own position, making it a factual research summary rather than a trade idea.
LOW
22:58
May 17
May 17
"Checkpoint Capital increased positions in ARGX, CYTK, RYTM in Q1 2026.
"Checkpoint Capital increased positions in ARGX, CYTK, RYTM in Q1 2026. Fund disclosure, no speaker thesis."
HIGH
About ARGX Analyst Coverage
Buzzberg tracks ARGX (argenx SE American Depositary Shares) across 6 sources. 1 bullish vs 0 bearish calls from 6 analysts. Sentiment: predominantly bullish (9%). 11 total trade ideas tracked. Latest voices: DeItaone, FirstSquawk, Bloomberg.